cost-effectiveness of a trap to capture the dengue adult vector in the context of the public health...
TRANSCRIPT
Cost-effectiveness of a trap to capture the dengue adult vector
in the context of the Public Health System in Brazil
Authors: Fabiana Raynal Floriano; Luis Eugenio Portela; Sebastião Loureiro; Martha Teixeira; Gimena M. Santos; Vanessa C.G.S. Morato; Maria da Glória Teixeira; Patrícia Barber; Naomar de Almeida Filho
Introduction
Source: http://www.cdc.gov/ncidod/dvbid/dengue/map-distribution-2005.htm
Figure 1: Distribution of Dengue around the world, 2005.
Source: http://www2.datasus.gov.br/DATASUS/index.php
Figure 2: Dengue incidence between 2001 and 2011 in Salvador, Bahia and Brazil.
Introduction Dengue’s impact on health services, society and
country’s economy. National Dengue Control Plan (PNCD) (Ministry of
Health, 2002). Strategies to eliminate the Aedes aegypti with
controversial efficacy new technologies are being developed and applied.
Mosquitrap - letal (Intelligent Monitoring System)
Source: http://www.ecovec.com/
midengue.php
Objective To estimate the cost-effectiveness of:
Trap to capture the dengue adult vector+ Usual program (Intervention area)
Usual program of dengue control (Control area).
Materials and Method Time horizon: 2011; Public Health System perspective: direct
medical costs Population: children aged 0-14 years Epidemiological indicators:
incidence; percentage distribution of dengue
according to dengue severity. Trap Effectiveness measure: Reduction of
the dengue incidence
Materials and Method - Costs Health Care Cost All stages of the disease progression (MH, 2011) Direct medical costs: diagnostic tests; drugs;
service: professional fees and hospitalization
Materials and Method - Costs Health Care Cost All stages of the disease progression (MH, 2011) Direct medical costs: diagnostic tests; drugs;
service: professional fees and hospitalizationTechnology Cost 3,232 traps deployment service monitoring and maintenance services: materials
and training
Materials and Method - Costs Health Care Cost All stages of the disease progression (MH, 2011) Direct medical costs: diagnostic tests; drugs;
service: professional fees and hospitalizationTechnology Cost 3,232 traps deployment service monitoring and maintenance services: materials
and trainingTotal Cost Control Area: Health Care Cost Intervention Area: Health Care Cost +
Technology Cost
Materials and MethodEffectiveness Prevented dengue cases
Cost-Effectiveness Decision tree analytical model
Sensitivity Analysis Effectiveness: highest and lowest dengue
incidence, in the last five years, in Salvador
Results
Table 1: Total cost (USD) of dengue treatment, according to risk classification, Salvador, Bahia, Brazil, 2011.
Costs of Health Care Group A (%) Group B (%) Group C (%) Group D (%) Direct medical costs Diagnostic tests 201.12 (86.67) 487.93 (90.12) 3,478.98(58.37) 4,911.45 (53.36) Professional fees and Hospitalization 11.78 (5.07) 27.26 (5.04) 2,445.69 (41.04) 4,030.96 (43.79)
Drugs 19.17 (8.26) 26.20 (4.84) 35.13 (0.59) 262.65 (2.85) Total Cost of Treatment 232.07 (100) 541.40 (100) 5,959.79 (100) 9,205.06 (100)
Results
Table 2: Dengue cases, total cost and cost average case (USD), in the intervention and control areas, Salvador, Bahia, Brazil, 2011.
Itens Intervention Area Control Area Difference Between Areas
Incidence 12.73% 14.38% -1.65
Dengue Case 69,533 78,545 -9,012
Treatment Cost 32,773,670.58 37,021,632.60 - 4,247,962.02
Technology Cost 2,770,471.25 0.00 2,770,471.25
Total Cost 35,544,141.83 37,021,632.60 - 1,477,490.77
Cost Average Case 511.19 471.34 39.85
Areas Cost (C)
Effectiveness (E) C/E Cost Effectiveness
(Prevented Cases) ICER
Intervention 35,544,141.83 69,533 511.19 - 1,477,490.76 -9,012 163.94
Control 37,021,632.60 78,545 471.34
Sensitivity Analysis
Highest Incidence
Intervention 57,118,639.83 115,305 495.37 - 4,283,720.22 -14,966 286.23
Control 61,402,360.04 130,217 471.54
Lowest Incidence
Intervention 8,357,184.93 11,853 705.07 2,023,859.75 -1,584 -1,277.68
Control 6,333,325.19 13,437 471.34
ResultsTable 3: Cost-Effectiveness (C/E), Incremental Cost-Effectiveness Ratio (ICER) and Sensitivity Analysis of control and intervention areas, Salvador, Bahia, Brazil, 2011.
Trap was effective Control area was dominated However, the sensitivity analysis showed
that the ICER varied according to the population’s disease incidence
Health managers must consider dengue incidence, before incorporating the trap
Conclusion
Bibliographical References1. BRASIL. Ministério da Saúde. Banco de Dados do Sistema Único de Saúde – DATASUS. http://www2.datasus.gov.br/DATASUS/index.php.2. BRASIL. Ministério da Saúde. Programa Nacional de Controle da Dengue. MS, FUNASA. Brasília: Ministério da Saúde, 2002. 34p.3. SIGTAP. http://sigtap.datasus.gov.br/tabela-unificada/app/sec/inicio.jsp.4. Banco de Preços do Ministério da Saúde. http://bps.saude.gov.br/login.cfm.5. BRASIL. Ministério da Saúde. Dengue: diagnóstico e manejo clínico: criança. MS, Secretaria de Vigilância em Saúde, Departamento de Vigilância Epidemiológica. – Brasília: Ministério da Saúde, 2011. 52p.6. BRASIL. Instituto Brasileiro de Geografia e Estatística – IBGE. http://www.ibge.gov.br/home/.7. BRASIL. Banco Central. Taxa de Câmbio. http://www4.bcb.gov.br/pec/conversao/conversao.asp. 8. ECOVEC. M.I. Dengue. http://www.ecovec.com/midengue.php.
Contacts:[email protected]
Web site:http://www.inct-citecs.ufba.br
http://www.isc.ufba.br/index.phphttp://www.pbct.inweb.org.br/pbct/